1. Home
  2. CVE Database
  3. CVE-2026-21980
MEDIUM · 6.5

CVE-2026-21980

Vulnerability in the Oracle Life Sciences Central Coding product of Oracle Health Sciences Applications (component: Platform). The supported version that is affected is 7.0.1.0. Easily exploitable v...

Vulnerability Description

Vulnerability in the Oracle Life Sciences Central Coding product of Oracle Health Sciences Applications (component: Platform). The supported version that is affected is 7.0.1.0. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences Central Coding. Successful attacks of this vulnerability can result in unauthorized update, insert or delete access to some of Oracle Life Sciences Central Coding accessible data as well as unauthorized read access to a subset of Oracle Life Sciences Central Coding accessible data. CVSS 3.1 Base Score 6.5 (Confidentiality and Integrity impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N).

CVSS Score

6.5

MEDIUM

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N
Attack Vector
NETWORK
Attack Complexity
LOW
Privileges Required
NONE
User Interaction
NONE
Scope
UNCHANGED
Confidentiality
LOW
Integrity
LOW
Availability
NONE

Affected Products

VendorProductVersions
OracleLife Sciences Central Coding7.0.1.0

References

FAQ

What is CVE-2026-21980?

CVE-2026-21980 is a vulnerability with a CVSS score of 6.5 (MEDIUM). Vulnerability in the Oracle Life Sciences Central Coding product of Oracle Health Sciences Applications (component: Platform). The supported version that is affected is 7.0.1.0. Easily exploitable v...

How severe is CVE-2026-21980?

CVE-2026-21980 has been rated MEDIUM with a CVSS base score of 6.5/10. Review the CVSS metrics above for detailed severity breakdown.

Is there a patch for CVE-2026-21980?

Check the references section above for vendor advisories and patch information. Affected products include: Oracle Life Sciences Central Coding.